|
CN106674217A
|
|
Racanisodamine crystal form and preparation method thereof
|
|
CN106353154A
|
|
Separation preparation method of tetrapeptide impurity in alanyl-glutamine injection
|
|
CN106432195A
|
|
Method for preparing (R)-2-(2-methylpyrrolidine-2-yl)-1H-benzimidazole-4-carboxamide
|
|
CN103641784A
|
|
Bendazac lysine synthesis process
|
|
CN102993102A
|
|
Synthetic method of [1-methyl-2-(8'-octyl hydroxamic acid group)-5-N,N-bi(2'-chloroethyl)]-1H-benzimidazole
|
|
CN103919779A
|
|
Medicinal composition containing moxifloxacin
|
|
CN101891663A
|
|
Preparation method of bicalutamide intermediate
|
|
CN102100688A
|
|
Application of zedoary cyclic diolefine in preparation of medicine for resisting neoplasm metastasis
|
|
CN101984961A
|
|
Furanodiene-containing medicinal composition, technology for preparing preparation thereof and medicinal use thereof
|
|
CN101985428A
|
|
O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof
|
|
CN101856342A
|
|
Pravastatin transdermal administration preparation and preparation method thereof
|
|
CN101786975A
|
|
Lipoamide series derivates, preparation method and pharmaceutical application thereof
|
|
CN101444526A
|
|
Pharmaceutical composition
|
|
CN101385862A
|
|
Sterilization filtration method of emulsion for injection
|
|
CN101402690A
|
|
Method for preparation of hydroxyethyl starch
|
|
CN101607936A
|
|
Gimeracil crystal form and preparation method thereof
|
|
CN101352449A
|
|
Vitamin orally disintegrating tablet and preparation method thereof
|
|
CN101332193A
|
|
Preparation method of fluvoxamine maleate medicine composition
|
|
CN101322720A
|
|
Arsenic trioxide emulsion for intravenous injection and preparation thereof
|
|
CN101322719A
|
|
Arsenic trioxide solid lipid nano granule and formulation
|
